0 Commentarii
0 Distribuiri
1K Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Autologous Cell Therapies and High-Throughput Disease Modeling Driving iPSC Platform AdoptionThe rapid evolution of cellular reprogramming technologies and regenerative medicine is positioning induced pluripotent stem cells (iPSCs) as a cornerstone of advanced biopharmaceutical R&D. Detailed analysis within the Induced Pluripotent Stem Cell Market report highlights how non-integrating reprogramming methods—including mRNA, episomal vectors, and Sendai virus...0 Commentarii 0 Distribuiri 118 Views 0 previzualizare
-
BCL-2 Family Inhibitors and Targeted Cell-Death Therapies Transforming the Oncology Apoptosis Modulator MarketTargeting cell-death evasion pathways to restore natural programmed cell death in malignant cells represents a cornerstone of modern targeted cancer therapy within the Oncology Apoptosis Modulator Market. Apoptosis modulators encompass small-molecule BCL-2 inhibitors (such as venetoclax), MCL-1 inhibitors, and IAP antagonists that disrupt anti-apoptotic protein complexes inside tumor cells....0 Commentarii 0 Distribuiri 29 Views 0 previzualizare
-
Engineered T-Cell Receptor Therapies and Intracellular Antigen Targeting Transforming Solid Tumor OncologyOvercoming the surface-antigen limitations of traditional CAR-T cell therapies is establishing T-cell receptor (TCR) engineered modalities as a major breakthrough for solid tumor oncology. Detailed analysis within the tcr therapy Market report demonstrates how TCR therapies genetically engineer patient T-cells to recognize intracellular tumor-specific peptides presented by human leukocyte...0 Commentarii 0 Distribuiri 109 Views 0 previzualizare
-
Giant Cell Arteritis Market Demand Rises with Expanding Access to Advanced TherapiesThe global giant cell arteritis market is projected to grow from USD 2.7 billion in 2026 to USD 6.0 billion by 2036, expanding at an 8.4% CAGR, according to Future Market Insights (FMI). Market growth is being supported by demand for targeted therapies, ongoing relapse management, and treatment strategies designed to reduce reliance on prolonged corticosteroid exposure. Giant cell arteritis...0 Commentarii 0 Distribuiri 270 Views 0 previzualizare
-
Hairy Cell Leukemia Treatment Market Trends: Targeted Therapies Shape Future Treatment DemandNEWARK, Del. — According to Future Market Insights (FMI), the global hairy cell leukemia treatment market is valued at USD 412.8 million in 2026 and is projected to reach USD 753.3 million by 2036, expanding at a 6.2% CAGR during the 2026–2036 forecast period. Established treatment guidelines and defined intervention criteria continue to support demand for therapies among patients...0 Commentarii 0 Distribuiri 183 Views 0 previzualizare
-
Inherited Cancer Syndrome Management: Emerging Therapies and the Future of Basal Cell Nevus Syndrome CareInherited cancer syndromes represent some of the most challenging conditions in modern medicine, requiring lifelong surveillance and management. Among these, basal cell nevus syndrome (Gorlin syndrome) is particularly burdensome due to the high number of skin cancers patients develop over their lifetime. The traditional approach has been reactive and invasive, but the landscape is changing...0 Commentarii 0 Distribuiri 286 Views 0 previzualizare
-
Primary Mediastinal Large B-Cell Lymphoma Treatment Market: Global Pharmaceutical Companies, Advanced Therapies and Industry Growth Outlook"According to the latest report published by Data Bridge Market Research, the Primary Mediastinal Large B-cell Lymphoma Treatment Market CAGR Value The global primary mediastinal large B-cell lymphoma treatment market size was valued at USD 850.00 million in 2025 and is expected to reach USD 1,354.77 million by 2033, at a CAGR of 6.00% during the forecast period The...0 Commentarii 0 Distribuiri 518 Views 0 previzualizare
-
Strategic Growth Opportunities in the Mesenchymal Stem Cell and Exosome Diagnostics and Therapies MarketThe regenerative medicine industry is experiencing significant transformation as cell-based and exosome-based therapies offer new hope for patients with chronic and degenerative diseases. The Mesenchymal Stem Cell and Exosome Diagnostics and Therapies Market is valued at USD 6.6 billion in 2025 and projected to reach USD 15 billion by 2035 at a CAGR of 8.6%. This article explores...0 Commentarii 0 Distribuiri 377 Views 0 previzualizare
-
The Separation Science: How Cell Separation Technology is Enabling the Next Generation of TherapiesThe ability to purify specific cell populations from complex mixtures is a fundamental prerequisite for many cutting-edge biomedical applications. Cell separation technology , particularly Fluorescence Activated Cell Sorting (FACS), has emerged as the gold standard for achieving high-purity, high-viability cell populations. The Fluorescence Activated Cell Sorting Market is...0 Commentarii 0 Distribuiri 283 Views 0 previzualizare
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek